J B Chemicals & Pharmaceuticals Financial Statements

J B Chemicals & Pharmaceuticals Annually Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 15.10 26 4.81 11.10
Op profit growth 48.40 73.30 (6.30) 12.80
EBIT growth 66.90 83.30 (16) 5.58
Net profit growth 64.70 96.60 (25) 13.20
Profitability ratios (%)        
OPM 27.40 21.30 15.50 17.30
EBIT margin 29.60 20.40 14 17.50
Net profit margin 21.90 15.30 9.82 13.70
RoCE 35 23.50 13.10 16.10
RoNW 6.90 4.73 2.47 3.61
RoA 6.49 4.42 2.29 3.16
Per share ratios ()        
EPS 58 35.30 16.60 21.70
Dividend per share 16.50 11 2 1
Cash EPS 49.10 26.60 9.74 16.10
Book value per share 234 186 172 161
Valuation ratios        
P/E 21.60 14.40 18.60 16
P/CEPS 25.50 19.10 31.80 21.50
P/B 5.35 2.74 1.79 2.16
EV/EBIDTA 14.40 9.17 10.20 10.50
Payout (%)        
Dividend payout -- -- 12.10 4.61
Tax payout (25) (21) (28) (20)
Liquidity ratios        
Debtor days 65.60 66.40 73.40 73.10
Inventory days 55.60 50.20 53.60 52.70
Creditor days (46) (38) (35) (37)
Leverage ratios        
Interest coverage (83) (119) (57) (44)
Net debt / equity -- -- -- 0.03
Net debt / op. profit -- -- -- 0.15
Cost breakup ()        
Material costs (34) (36) (38) (39)
Employee costs (17) (18) (18) (16)
Other costs (22) (25) (29) (27)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 2,043 1,775 1,409 1,344
yoy growth (%) 15.10 26 4.81 11.10
Raw materials (701) (631) (538) (528)
As % of sales 34.30 35.50 38.20 39.30
Employee costs (341) (323) (251) (217)
As % of sales 16.70 18.20 17.80 16.20
Other costs (440) (443) (402) (367)
As % of sales 21.50 25 28.50 27.30
Operating profit 560 378 218 232
OPM 27.40 21.30 15.50 17.30
Depreciation (69) (66) (57) (47)
Interest expense (7.20) (3) (3.50) (5.40)
Other income 112 50.70 36.60 50.20
Profit before tax 597 359 194 230
Taxes (148) (77) (55) (46)
Tax rate (25) (21) (28) (20)
Minorities and other (0.60) (0.30) (0.40) (0.30)
Adj. profit 448 282 138 184
Exceptional items -- (10) -- --
Net profit 448 272 138 184
yoy growth (%) 64.70 96.60 (25) 13.20
NPM 21.90 15.30 9.82 13.70
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 597 359 194 230
Depreciation (69) (66) (57) (47)
Tax paid (148) (77) (55) (46)
Working capital 50.30 18.10 65.20 37.80
Other operating items -- -- -- --
Operating cashflow 430 234 147 175
Capital expenditure 762 721 516 498
Free cash flow 1,192 955 663 673
Equity raised 2,020 2,100 2,306 2,197
Investments 593 101 36.10 (89)
Debt financing/disposal (53) 47.40 12.30 24.50
Dividends paid -- -- 16.70 8.48
Other items -- -- -- --
Net in cash 3,751 3,203 3,035 2,814
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 15.50 15.50 16.10 16.70
Preference capital -- -- -- --
Reserves 1,794 1,420 1,464 1,425
Net worth 1,810 1,435 1,480 1,442
Minority interest
Debt 32.60 29.50 25.80 29.30
Deferred tax liabilities (net) 72.10 64.10 77.20 69.30
Total liabilities 1,918 1,532 1,586 1,543
Fixed assets 659 667 636 657
Intangible assets
Investments 678 403 457 434
Deferred tax asset (net) 22.30 16 20.30 36.90
Net working capital 528 414 436 385
Inventories 347 275 244 214
Inventory Days 62.10 56.50 -- 55.40
Sundry debtors 389 345 308 301
Debtor days 69.50 71 -- 77.90
Other current assets 127 92.20 111 130
Sundry creditors (194) (176) (119) (114)
Creditor days 34.70 36.20 -- 29.60
Other current liabilities (141) (123) (107) (145)
Cash 30.90 31 36.80 29.90
Total assets 1,918 1,532 1,586 1,543
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2021 Mar-2020 Mar-2019 Mar-2018 Mar-2017
Gross Sales 2,043 1,775 1,643 1,413 1,368
Excise Duty -- -- -- -- --
Net Sales 2,043 1,775 1,643 1,413 1,368
Other Operating Income -- -- -- -- --
Other Income 112 50.70 41.40 37.10 50.20
Total Income 2,155 1,825 1,685 1,450 1,418
Total Expenditure ** 1,482 1,407 1,337 1,196 1,136
PBIDT 673 418 347 254 283
Interest 7.24 3.03 4.65 3.49 5.37
PBDT 666 415 343 251 277
Depreciation 68.70 66.30 55.60 57 47.20
Minority Interest Before NP -- -- -- -- --
Tax 142 84.40 93 55.20 45.60
Deferred Tax 6.16 (7.90) -- -- --
Reported Profit After Tax 449 272 194 139 184
Minority Interest After NP 0.56 0.35 0.50 0.38 0.34
Net Profit after Minority Interest 448 272 193 138 184
Extra-ordinary Items -- (7.60) -- -- --
Adjusted Profit After Extra-ordinary item 448 280 193 138 184
EPS (Unit Curr.) 58 34.20 23.50 16.50 21.70
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) 825 550 250 100 50
Equity 15.50 15.50 16.10 16.70 17
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 32.90 23.60 21.10 18 20.60
PBDTM(%) 32.60 23.40 20.90 17.80 20.30
PATM(%) 22 15.30 11.80 9.82 13.50
Open ZERO Brokerage Demat Account
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity